<?xml version="1.0" encoding="ISO-8859-1"?>

<rss version="2.0">
<channel>
<title>ALK-Abelló - PRWeb Press Release Group</title>
<link>http://www.rsspad.com/rss2/17350.xml</link>
<description>ALK-Abelló - Powered by PRWeb and RSSPad</description>
<language>en</language>
<managingEditor>xml@emediawire.com</managingEditor>
<webMaster>xml@emediawire.com</webMaster>
<ttl>30</ttl>
<item>
         <title>ALK-Abell&amp;oacute;, the makers of GRAZAX&amp;reg;, Welcome GA2LEN New Hay Fever and Asthma Campaign</title>
         <link>http://www.prweb.com/releases/2007/04/prweb521771.htm</link><description>   <![CDATA[ <P>ALK-Abell&oacute; has today welcomed the information campaign from the Global Allergy and Asthma European Network, GA2LEN, entitled 'Does Rhinitis lead to Asthma?' launched last week at the network's Annual Conference in London, UK. (PRWeb Apr 27, 2007)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2007/04/prweb521771.htm">http://www.prweb.com/releases/2007/04/prweb521771.htm</a></P>]]>
                </description>
<pubDate>Fri, 27 Apr 2007 07:00:00 GMT</pubDate><guid isPermaLink="true">http://www.prweb.com/releases/2007/04/prweb521771.htm</guid> </item>
</channel>
</rss>